Keith Chan Selected Research

Protease Inhibitors (Protease Inhibitor)

8/2014

Temporal trends in the discontinuation of first-line antiretroviral therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keith Chan Research Topics

Disease

8	Acquired Immunodeficiency Syndrome (AIDS) 10/2017 - 04/2008
3	Infections 06/2021 - 02/2005
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2022
2	Abscess 01/2021 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020 - 01/2020
2	HIV Infections (HIV Infection) 07/2012 - 03/2007
2	Wounds and Injuries (Trauma) 06/2010 - 05/2002
1	Cognitive Dysfunction 12/2022
1	Alzheimer Disease (Alzheimer's Disease) 12/2022
1	Ulcerative Colitis 06/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2018
1	Neoplasms (Cancer) 01/2018
1	Fatigue 09/2017
1	Migraine Disorders (Migraine) 09/2017
1	Sleepiness 09/2017
1	Vomiting 09/2017
1	Glycogen Storage Disease Type II (Pompe's Disease) 04/2017
1	Macular Degeneration (Age-Related Maculopathy) 11/2015
1	Smear Layer 05/2015
1	Mental Disorders (Mental Disorder) 11/2011
1	Femoral Fractures (Femoral Fracture) 06/2010
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2006
1	Disease Progression 02/2006
1	Alcoholism (Alcohol Abuse) 04/2005
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2003
1	Needlestick Injuries (Needlestick Injury) 05/2002
1	Immune Reconstitution Inflammatory Syndrome 02/2002
1	Lymphadenitis (Adenitis) 02/2002

Drug/Important Bio-Agent (IBA)

2	pembrolizumabIBA 01/2022 - 01/2018
2	cemiplimabIBA 01/2022 - 01/2022
2	NivolumabIBA 01/2021 - 12/2020
2	axicabtagene ciloleucelIBA 12/2020 - 01/2020
2	tisagenlecleucelIBA 12/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 01/2013 - 04/2005
1	NeurotoxinsIBA 12/2022
1	LigandsIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	tofacitinibIBA 06/2021
1	vedolizumabIBA 06/2021
1	trametinibIBA 01/2021
1	InterferonsIBA 01/2021
1	IpilimumabIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	dabrafenibIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	Dextrans (Dextran)FDA Link 01/2021
1	Irritants (Vesicants)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Brentuximab VedotinIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Tryptamines (Triptans)IBA 09/2017
1	almotriptan (Axert)FDA Link 09/2017
1	frovatriptan (Allegro)FDA Link 09/2017
1	human GAA protein (Myozyme)FDA Link 04/2017
1	afliberceptIBA 11/2015
1	Ranibizumab (Lucentis)FDA Link 11/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 08/2014
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 06/2010
1	NitritesIBA 03/2007
1	Vasodilator Agents (Vasodilators)IBA 03/2007
1	SmokeIBA 03/2006
1	VaccinesIBA 02/2005
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2002

Therapy/Procedure

11	Therapeutics 06/2021 - 05/2002
8	Highly Active Antiretroviral Therapy (HAART) 01/2014 - 02/2002
1	Drug Therapy (Chemotherapy) 01/2022
1	Subcutaneous Injections 01/2021
1	Complementary Therapies (Alternative Medicine) 09/2017
1	Enzyme Replacement Therapy 04/2017
1	Lasers (Laser) 05/2015
1	Length of Stay 04/2003